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Attention has long been paid to the mysterious nature of the mind’s impact on 
physiologic function. This has been central to medicine whether disseminated as anecdotal and 
cliché in nature or founded in science. Interest has been increasing as patients and providers alike 
become fascinated with integration of western and eastern approaches to medicine. Diet and 
exercise are consistent components of clinician mantra. Recently though, integrated terms like 
mindful meditation, yoga, and spiritual healing are growing in popularity and reframing lifestyle 
change interventions. These terms will be collectively referred to as mind-body exercises (MBE), 
unless any distinction is necessary.  
Heart disease has been the leading cause of death for nearly one hundred years in the 
United States despite large efforts from healthcare providers to educate, prevent, and treat 
cardiovascular diseases (CVD).1,2 Diet and exercise have been implemented as first line therapy 
to improve cardiovascular health, prevent CVD, treat hypertension, and improve blood 
cholesterol values. The second approach is utilizing an arsenal of medications with varying 
efficacy and side effect profiles. As alternative medicine has become more popular, patients are 
becoming increasingly skeptical of these medications. At the same time compelling evidence for 
non-pharmaceutical options outside of dietary modification and physical fitness is growing. 
Studies show a strong link between MBE and improving cardiovascular measures. The goal of 
this literature review is to elucidate what parameters are most susceptible to MBEs, how those 
parameters can be modified to reduce CVD risk, and how the knowledgeable clinician can utilize 
MBEs to optimize patient-centered care. This review will demonstrate a judicious clinical 
approach to interpreting current recommendations for treating CVD patients and understanding 
what about the current model can be improved upon and what patient demographics should be 
considered when prescribing MBE.   
 
Discussion 
 The mind has an immense impact on objective measures related to cardiac function, 
stress levels, and autonomic nervous system function. Cardiac measures that most reliably 
predict CVD include hypertension, hyperlipidemia, and smoking.3  
Hypertension 
Review of Systolic Blood Pressure Intervention Trials (SPRINT) shows that normal 
blood pressure can be considered a systolic blood pressure (SBP) less than or equal to 120. 
Hypertension is universally accepted as an indirect measure of cardiac function and risk for 
adverse outcomes. In addition, SPRINT studies demonstrate that an increase in SBP above 
normal is correlated with heart failure and higher mortality.4 Therefore, there is a large incentive 
to reduce patients’ SBP to a normal level to improve cardiac function, decrease heart failure and 
decrease mortality due to CVD.5 
 First-line treatment for high blood pressure begins with life-style changes but review of 
the literature shows that most patients are started on pharmacotherapy and end up on multiple-
drug regimens to achieve adequate control.6 The importance of implementing lifestyle changes is 
often glossed over and in practice is often mentioned only briefly, or not at all.  
Realistically, there is a lot of potential for lowering blood pressure with MBE. Although 
limited to a small sample size, one randomized control study analyzing yoga as an intervention in 
hypertensive patients showed decrease in blood pressure compared to control.7,8 Many studies 
determine the same trend but neglect to compare this to pharmacotherapy in terms of efficacy.9 
Without comparative studies pharmacotherapy introduces variables of concern to patients such 
as adverse reactions, non-compliant exacerbations, or even a false understanding that medication 
has treated their high blood pressure. These can be minimized with proper education.  
 One meta-analysis notes variable response to different MBEs. Notably more significant 
decreases in blood pressure were seen in patients less than sixty years old when using a high 
cardiovascular demand MBE like high intensity yoga. Contrast this with patients greater than 60 
years old that respond more effectively to mindfulness and more breathing exercise-based forms 
of meditation.10 Criticism from most reliable sources like the American Heart Association meta-
analysis like these primarily focus on the sample size and high drop-out rates of individual 
studies.8  
Drawbacks in terms of the literature do not consider the practical benefits of MBE. Low 
cost and improved sense of well-being are most difficult to put into scientific terms but may be at 
the forefront of reasons to implement these options with patients over or concurrent with 
pharmacotherapy.  
Dyslipidemia and Atherosclerosis 
Hyperlipidemia and atherosclerosis contribute significantly to CVD risk.3 Lipid profiles 
are commonly measured in outpatient settings in order to stratify patients into vulnerability to 
develop CVD or ischemic and thrombotic events, and therefore is an important variable to 
consider when examining MBEs. The current literature demonstrates that MBEs are not as 
straight forward in their impact on dyslipidemia. In a study comparing meditation to exercise on 
a large number of measures shows that exercise is more effective at lowering blood markers such 
as LDL and fasting blood sugar and improving HDL levels. Silent and akinetic versions of MBE, 
like meditation have better outcomes related to pain, altruism, and anxiety.11 MBEs that have 
higher oxygen demand have effects more related to exercise. Yoga, for example, which requires 
participants to maintain positions with significantly active muscle tone compared to relaxation-
type meditation, has a remarkably beneficial impact on increasing HDL and decreasing LDL and 
triglycerides.12 The implication of this difference between high oxygen demand MBE and 
akinetic versions is a requirement of the clinician to work with patients to prioritize patient goals. 
There is a lot of ability for a clinician to individualize intervention when using MBE modalities.  
Central Nervous System 
MBE can also be used in various other capacities that relate to CVD. Stress is a daily 
occurrence for most people, and it has a notable contribution to CVD risk factors. Autonomic 
nervous system (ANS) balance is a big indicator of how susceptible to someone is to stress 
related illness. Robert Sapolsky, a professor of biological science at Stanford University and 
professor of neurology and neurosurgery at Stanford’s School of Medicine elucidates that the 
patient with chronic stress decreases parasympathetic tone and worsens cardiovascular 
measures.13 With pathologically less parasympathetic tone due to stress, increases in heart rate 
and blood pressure lead to CVD as previously discussed. Studies have shown that the mechanism 
of this autonomic nervous system pathology can be reversed with decreasing stress. One of these 
is examples is seen in former drug addicts. Heavy substance abuse causes remarkable stress on 
the body and blunts the nervous system’s ability to display parasympathetic tone. Pathological 
stress and overactive sympathetic nervous system (SNS) over parasympathetic nervous system 
(PNS) was shown to be reversed in a trial with ex-drug addicts practicing Zen yoga.14 It can be 
said then, that MBEs improves the responsiveness and contrast between parasympathetic tone 
and sympathetic tone. 
MBEs have an impact on mental measures of patient health. Optimizing vagus nerve 
stimulation due to improved ANS function in chronically stressed individuals can improve 
patients’ perceptions of their own illnesses, build better rapport with healthcare providers, and 
predict higher compliance rates with treatment plans.15 This means ANS function can improve 
CVD by directly stimulating PNS and can indirectly improve by improving compliance to 
pharmacotherapy and patient follow up associated with CVD. Additional research shows a 
correlation with lower burnout rates in high demand occupations.16  This array of improvement 
for patients is especially a consideration for primary care providers emphasizing prevention and 
taking a wholistic approach to patient care.  
The clinician must also consider patient demographics associated with use of MBE. A 
study analyzing women diagnosed with breast cancer showed that women of higher education 
and more recent diagnosis were more likely to use MBE in place of or in conjunction with other 
therapy.17 Judicious use of assessing patient buy-in to MBE can optimize efficacy and improve 
patient outcomes. This is especially important to consider if newly diagnosing patients with CVD 
risk factors or CVD since this may improve patient motivation for MBE as a therapy.  
 
Conclusion 
 MBE has been shown to reduce blood pressure, improve lipid profiles, and autonomic 
nervous system function related to stress. Most studies demonstrating these valuable points are 
limited in size and therefore may lack generalizability. More research needs to be done to 
support or refute current research. There is a lack of studies directly comparing MBE to 
pharmacotherapy in terms of efficacy. Other variables may also be considered, such as 
inflammatory markers and mortality in patients practicing MBE. Positive implications on 
compliance of other therapeutics and general patient motivation should be considered when 
suggesting MBE. Factors regarding patient demographics such as education level, age, and 
recent diagnoses must be carefully understood for prudent use of MBE in adjunct with 
pharmacotherapy. The variety of MBE modalities also allow the patient and clinician to 
personalize the use of MBE to target desired metabolic measures, such as blood pressure and 
lipid profiles or improve mental health, such as anxiety and pain.  
 It appears that in line with most clinical interventions MBE should not be a monotherapy 
and there are variables that make the provider prescribing MBE more appropriate. MBE is 
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